An Assay Suitable for High Throughput Screening of Anti-influenza Drugs

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Jan 18

PMID 23326573

Citations 2

Authors

Lili Mao

Jun Wang

William F DeGrado

Masayori Inouye

Affiliations

Soon will be listed here.

Abstract

We developed a novel drug screening system for anti-influenza A virus by targeting the M2 proton channel. In the SPP (Single Protein Production) system, E. coli cell growth occurs only in the presence of effective M2 channel inhibitors, and thus simple measurement of cell growth was used as readouts for drug screening. Two potential inhibitors for M2 (V27A) mutant were verified using this method, which inhibit both the mutant and wild-type M2 channels.

Citing Articles

Identification of pyrvinium pamoate as an anti-tuberculosis agent and by SOSA approach amongst known drugs.

Guan Q, Zhan L, Liu Z, Pan Q, Chen X, Xiao Z Emerg Microbes Infect. 2020; 9(1):302-312.

PMID: 32013776 PMC: 7034053. DOI: 10.1080/22221751.2020.1720527.

Bacteria-based analysis of HIV-1 Vpu channel activity.

Taube R, Alhadeff R, Assa D, Krugliak M, Arkin I PLoS One. 2014; 9(10):e105387.

PMID: 25272035 PMC: 4182682. DOI: 10.1371/journal.pone.0105387.

References

Jing X, Ma C, Ohigashi Y, Oliveira F, Jardetzky T, Pinto L . Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel. Proc Natl Acad Sci U S A. 2008; 105(31):10967-72. PMC: 2492755. DOI: 10.1073/pnas.0804958105. View

Moscona A . Neuraminidase inhibitors for influenza. N Engl J Med. 2005; 353(13):1363-73. DOI: 10.1056/NEJMra050740. View

Astrahan P, Flitman-Tene R, Bennett E, Krugliak M, Gilon C, Arkin I . Quantitative analysis of influenza M2 channel blockers. Biochim Biophys Acta. 2010; 1808(1):394-8. DOI: 10.1016/j.bbamem.2010.08.021. View

Mould J, Drury J, Frings S, Kaupp U, Pekosz A, Lamb R . Permeation and activation of the M2 ion channel of influenza A virus. J Biol Chem. 2000; 275(40):31038-50. DOI: 10.1074/jbc.M003663200. View

Suzuki M, Mao L, Inouye M . Single protein production (SPP) system in Escherichia coli. Nat Protoc. 2007; 2(7):1802-10. DOI: 10.1038/nprot.2007.252. View

Ohshima M, Inoue K, Hayashi H, Tsuji D, Mizugaki M, Itoh K . Generation of AcGFP fusion with single-chain Fv selected from a phage display library constructed from mice hyperimmunized against 5-methyl 2'-deoxycytidine. Protein Eng Des Sel. 2010; 23(11):881-8. DOI: 10.1093/protein/gzq066. View

Balannik V, Carnevale V, Fiorin G, Levine B, Lamb R, Klein M . Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel. Biochemistry. 2009; 49(4):696-708. PMC: 4924815. DOI: 10.1021/bi901799k. View

De Clercq E . Antiviral agents active against influenza A viruses. Nat Rev Drug Discov. 2006; 5(12):1015-25. PMC: 7097821. DOI: 10.1038/nrd2175. View

Monto A . Vaccines and antiviral drugs in pandemic preparedness. Emerg Infect Dis. 2006; 12(1):55-60. PMC: 3291404. DOI: 10.3201/eid1201.051068. View

10.

Wang J, Ma C, Wu Y, Lamb R, Pinto L, DeGrado W . Exploring organosilane amines as potent inhibitors and structural probes of influenza a virus M2 proton channel. J Am Chem Soc. 2011; 133(35):13844-7. PMC: 3166227. DOI: 10.1021/ja2050666. View

11.

Griffin S . Plugging the holes in hepatitis C virus antiviral therapy. Proc Natl Acad Sci U S A. 2009; 106(31):12567-8. PMC: 2722315. DOI: 10.1073/pnas.0906760106. View

12.

Hout D, Mulcahy E, Pacyniak E, Gomez L, Gomez M, Stephens E . Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1. Curr HIV Res. 2004; 2(3):255-70. DOI: 10.2174/1570162043351246. View

13.

Wang J, Ma C, Fiorin G, Carnevale V, Wang T, Hu F . Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2. J Am Chem Soc. 2011; 133(32):12834-41. PMC: 3354620. DOI: 10.1021/ja204969m. View

14.

Balannik V, Wang J, Ohigashi Y, Jing X, Magavern E, Lamb R . Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus. Biochemistry. 2009; 48(50):11872-82. PMC: 2794939. DOI: 10.1021/bi9014488. View

15.

Suzuki M, Zhang J, Liu M, Woychik N, Inouye M . Single protein production in living cells facilitated by an mRNA interferase. Mol Cell. 2005; 18(2):253-61. DOI: 10.1016/j.molcel.2005.03.011. View

16.

Thompson W, Shay D, Weintraub E, Brammer L, Cox N, Anderson L . Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289(2):179-86. DOI: 10.1001/jama.289.2.179. View